Treatment & Technology · For companies & clinicians

Industry & technology partners

Where device makers and researchers can get new PVC technology in front of the patients and doctors who need to know it exists.

Why this page exists

Getting new technology in front of the right people

Mapping systems, catheters, and ablation tools keep advancing — but that progress doesn't help patients if it stays buried in trade publications and conference posters. This page exists to let companies and researchers highlight new PVC-relevant technology in a way patients and doctors can actually find and understand.

For companies & researchers

How to submit a technology update

Submissions are reviewed and lightly edited for plain-language readability before publishing — technical accuracy stays intact, but the framing is patient-first. Use this structure when you submit:

Title
e.g., "New Mapping Technology for Difficult PVC Locations"
What is this?
A simple explanation of the technology, in plain language.
Why does it matter?
  • Better mapping near sensitive areas (like the His bundle)
  • Potentially safer ablation approaches
Who is it for?
  • Patients with difficult-to-treat PVCs
  • Cases where standard ablation is risky
What stage is it in?
  • Early research
  • Clinical use
  • Limited availability
Source
Company, study, or link.

Ready to submit an update?

Reach out through our contact form and select "Company / clinic technology submission."

Go to Contact →
General contact info

Major device developers

General corporate contacts for major companies building mapping systems, catheters, and ablation technology. These are starting points for researchers and clinicians — patients should direct treatment questions to their own EP, not to these companies directly.

2026 update:

The mapping/ablation supplier landscape has moved quickly. Several major players now offer pulsed-field ablation (PFA) platforms alongside their established RF systems — but it's worth knowing that current FDA approvals for these PFA systems are principally for atrial fibrillation, not a blanket approval for routine PVC treatment. For PVCs specifically, PFA use may be investigational, off-label, or limited to specialized centers, depending on the device.[a]

Abbott Laboratories

Cardiovascular devices
Current platforms
EnSite X mapping platform; RF ablation tools; the Volt pulsed-field ablation system, FDA-approved for atrial fibrillation as of December 2025.[b]
Corporate HQ
100 Abbott Park Road, Abbott Park, IL 60064
(224) 667-6100
Cardiovascular Division
5050 Nathan Lane North, Plymouth, MN 55442
(651) 756-5400
Website
abbott.com

Johnson & Johnson — Biosense Webster

J&J MedTech
Current platforms
CARTO mapping platform with an established RF catheter portfolio; also now offers the VARIPULSE pulsed-field platform.
Corporate address
33 Technology Drive, Irvine, CA 92618
(909) 839-8500
Customer service (US)
1-800-729-9010
US hotline
1-866-473-7823
Website
biosensewebster.com

Medtronic

Cardiac devices
Current platforms
Mapping, navigation, and ablation offerings, plus the PulseSelect and Affera Sphere-9 pulsed-field ablation platforms.
HQ (Cardiac Devices)
8200 Coral Sea Street NE, Mounds View, MN 55112
General customer support
1-800-238-2518
Website
medtronic.com

Boston Scientific

Farapulse / Pulsed Field Ablation
Current platforms
Rhythmia mapping platform and the FARAPULSE pulsed-field ablation system.
Farapulse education & specialist inquiries
1-855-442-7725
Mon–Fri, 8 AM–5 PM CST
Website
bostonscientific.com · farapulse.com

Acutus Medical

Advanced cardiac mapping
Current platforms
Advanced mapping technology for complex arrhythmia cases. Market role and product availability vary by center — confirm directly before referencing a specific patient case.
Website
acutusmedical.com

AtriCure

Ablation systems
Corporate HQ
7555 Innovation Way, Mason, OH 45040
+1 (513) 755-4100
Toll free
+1 (866) 349-2342
Fax
+1 (513) 755-4567
Website
atricure.com

AngioDynamics

NanoKnife, Solero MTA
Corporate HQ
14 Plaza Drive, Latham, NY 12110
General / IP queries
1-518-795-1400
Clinical / adverse event support
1-800-833-9973
Website
angiodynamics.com

For a patient, the specific brand usually matters less than whether the center and operator have strong experience mapping and ablating at your PVC's specific anatomic site.

References for this update:

  1. Current FDA approval status of pulsed-field ablation systems (principally atrial fibrillation, not routine PVC treatment) — see FierceBiotech and TCTMD coverage of Abbott's Volt system approval, December 2025.
  2. Abbott Volt™ Pulsed Field Ablation System FDA approval announcement, December 22, 2025. (Abbott newsroom)

Full source URLs available on request — several were provided as reference links in the source material for this update and can be added directly once verified.

A note on this list:

These are general corporate contacts, not endorsements of any specific product. Inclusion here reflects relevance to PVC mapping and ablation technology, not a claim about safety or effectiveness beyond what's documented on our Safety & Evidence and Emerging Technology pages.